Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Prediction of PD-1 immunotherapy (IO) response for KRAS mutated non-small cell lung cancer (NSCLC) based on co-mutations using a computational biological model. Annals of oncology : official journal of the European Society for Medical Oncology Wakelee, H., Aredo, J., Vali, S., Singh, N. K., Vasista, S. V., Mitra, U., Abbasi, T., Padda, S. K. 2018; 29 Suppl 8: viii510–viii511
View details for DOI 10.1093/annonc/mdy292.036
View details for PubMedID 32137320